Latest News
The Industry Birth of Home Health Diagnostics and Treatment
It Began with COVID-19, Now One Startup May Disrupt the Healthcare Industry - Unlocking the Future to Consumer Health Empowerment Ft. Lauderdale, Florida, June 14, 2022 By: Rae X Clear Health Pass, LLCBrand Warrior/Media RelationsPhone:800-266-7207 Ext...
COVID Reinfection, The New Normal?
Previous variants of the Coronavirus provided high levels of natural immunity post-infection, mutations of the Omicron strain are changing the game.... again. June 3rd, 2022 Just when we seem to get a grip on the Coronavirus, scientists and data shows new reports and...
‘We’re playing with fire’: US COVID cases may be 30 times higher than reported
We've known for some time now that COVID cases were largely being missed due to under-reporting of at-home tests, but a new study shows that number may be much bigger than we thought. "The United States is now in its fourth-biggest Covid surge, according to official...
Mask Up for Memorial Day
With holiday festivities right around the corner, it's important for everyone to have the information they need to protect themselves and their families. Unfortunately in the last 14 days, the United States has seen a 40% jump in new cases according to data tracked by...
A COVID Test Above the Rest
“WAIT, it doesn’t have to go up my nose!?” We hear in the background of our morning meeting as Julianne’s (Co-Master Distributor of Clear Health Pass) pre-teen daughter over-hears that our new COVID Test (COMING SOON) will not have to be administered with a nasal...
The Dangers of Growing False Negative Rates
How shortfalls of the current COVID test market affect us personally and globally April 15, 2022 On January 8th, 2021 the FDA Released a Statement that "false negative results may occur with any molecular test for the detection of SARS-CoV-2 if a mutation occurs in...
The Pandemic Is NOT Over
Based on multiple complicating factors we may be heading into a tsunami sized wave of new COVID cases
Omicron
What You Need to Know: Omicron (B.1.1.529) South African Variant Clear Health Pass Covid Pandemic Update: December 06, 2022 The B.1.1.529 variant was first reported to the World Health Organization (WHO) from South Africa on November 24, 2021. The epidemiological...
Study: Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review
It is unclear whether more timely cancer diagnosis brings favourable outcomes, with much of the previous evidence, in some cancers, being equivocal. We set out to determine whether there is an association between time to diagnosis, treatment and clinical outcomes, across all cancers for symptomatic presentations.
Study: Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous
Monocytes are a group of immune cells that originate in bone marrow and are released into peripheral blood, where they circulate for several days1,2. They belong to the mononuclear-phagocyte system, which also include macrophages, dendritic cells and their bone-marrow precursors3,4,5. Monocytes represent 5–10% of peripheral leucocytes and are probably best known for serving as a systemic reservoir of myeloid precursors that are needed for the renewal of tissue macrophages and dendritic cells6,7,8,9. However, they also have other well documented functions in immune response against infection10,11,12,13 and in pathogenesis of several inflammatory disorders. Although initially perceived as a homogeneous population, it has become increasingly apparent that monocytes display considerable heterogeneity with respect to their phenotype and function1,2,14,15.
Study: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes
Immunoglobulin G (IgG) antibody subclasses play major roles in the control of bacterial and viral infections, the killing of tumour cells during antibody therapy and the pathological destruction of healthy tissues in autoimmune diseases. As a result of their potency and range of actions, antibodies have become one of the most rapidly growing classes of human therapeutics in recent years, particularly in cancer treatments.
Study: Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients
Covid-19 can involve multiple organs including the nervous system. We sought to characterize the neurologic manifestations, their risk factors, and associated outcomes in hospitalized patients with Covid-19.
Study: Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19
Optical biosensors have led to significant advancements in virus detection and imaging capabilities. Coupled with advanced instrumentation, they have enabled higher sensitivities while increasing the rate at which samples can be tested. These techniques can be developed into point-of-care (POC) diagnostics for viral detection and are promising alternatives to detect COVID-19.
Study: SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiology of coronavirus disease 2019 (COVID-19), is readily transmitted person to person. Optimal control of COVID-19 depends on directing resources and health messaging to mitigation efforts that are most likely to prevent transmission, but the relative importance of such measures has been disputed.
Study: Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has caused a global pandemics. To facilitate the detection of SARS-CoV-2 infection, various RT-LAMP assays using 19 sets of primers had been developed, but never been compared.